Roche to buy U.S. biotech firm InterMune for $8.3 billion

[riky]

Roche to buy U.S. biotech firm InterMune for $8.3 billion

<p><a href="http://news.yahoo.com/roche-buy-u-biotech-firm-intermune-8-3-163303665--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/4RzcCCRF97UTA8mD.hTn9w--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-08-24T210850Z_1006950002_LYNXMPEA7N0AQ_RTROPTP_2_CBUSINESS-US-INTERMUNE-ROCHE.JPG" width="130" height="86" alt="The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai" align="left" title="The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai" border="0" /></a>By Ben Hirschler and Caroline Copley LONDON/ZURICH (Reuters) - Roche Holding AG has agreed to buy U.S. The Swiss drugmaker said on Sunday it would pay $74.00 a share through a tender offer for InterMune, representing a premium of 38 percent to the closing price on Aug. 22. The acquisition, which has been recommended by the boards of both companies, is the largest by Roche since 2009, when it bought out the remaining stake it did not already own in U.S. Chief Executive Severin Schwan said the deal would allow Roche to broaden and strengthen its respiratory portfolio, adding he believed there was a good strategic and cultural fit between Roche and the California-based biotech firm.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login